The Rosenman Innovators
Helping entrepreneurs bring life-changing healthtech to market in a big way. Applications for the 2021 cycle are now closed. Demo Day is June 10.
Jumpstart Your Innovation
Apply to Be a Rosenman Innovator.
Connect with people who can speed up your scale-up in healthtech: subject matter experts, clinicians, partners and investors. Applications for 2021 are now closed. Investors: contact us to learn how to get involved.Contact Us
Our hands-on mentorship, guidance, and the program’s suite of benefits help you navigate the path to commercialization like the insider you will soon be.
Have a question? See our FAQ below.
How It Works
All sessions are virtual.
Each spring, we invite startups in diagnostics, digital health, health services, and medical devices to pitch our panel of judges (a mix of financial/strategic investors, subject matter expertise and clinicians).
The judges select 10-12 companies who:
Who Can Apply
Special Track: TB Diagnostics
Are you developing a technology to diagnose and treat tuberculosis? Have you thought about adapting your SARS-CoV-2 diagnostic technology to the biggest killer globally every year in infectious disease?
This year, we offer an opportunity for relevant companies/academic developers. If selected for the 2021 Rosenman Innovator cohort, you will be connected to partners at the Rapid Research in Diagnostics Development (R2D2) for TB Network who can provide specimens to further develop your diagnostic technology, facilitate clinical trials and connect you to key stakeholders.
A core group of investors supports the Rosenman Innovator program and the Institute through the year.
“Tiatros is very lucky to be a Rosenman Innovator. The program fostered our collaboration with the San Francisco Veteran Affairs Health Care System. We look forward to continuing to explore ways to serve Veterans in the VA system.”
“The Rosenman Innovators program helped Moray Medical with wonderful mentors and services (including access to the very impressive Gore Innovation Center) during the program. What has been even better is the continuing support of the Rosenman Institute community after the program, including an introduction to the lead investor of our recent $3.3 million round!”
“The Rosenman Innovator program was a fantastic experience and opportunity to get exposure to seed-stage healthcare investors and other industry stakeholders. We met two investors who participated in our round through the program.”
“We connected with early-stage investors key to closing our seed round and raising more than $2 million in grant funding. The services provided by Cannon Quality Group included more than six months of manufacturing in a controlled environment and strategic continued input to our QMS that helped us advance significantly over a short period of time.”
“Through Rosenman Innovators, we were able to partner with Bayflex Solutions to conduct essential mechanical and stress testing of our product.”
“The Innovator program connected us with mentors who were successful founders, sophisticated investors, and scientific experts. This unique model enabled us to accelerate our progress over a few short months, successfully raise our seed round, and expand our advisory board. We have loved being a part of the Rosenman community and highly recommend the Rosenman Innovator program to any medical device or technology startup! “
“The Rosenman Innovator program was game-changing for our company. We [met] several highly-experienced mentors whose guidance helped us make drastic changes in our organization and strategy… and optimize our commercial path.”
“Liv Labs adopted a more aggressive plan and visionary scope as a result of intensive peer and investor mentoring in preparation for the Rosenman Innovator program pitch.”
Our participating service partners will choose the recipients of their services from among the Rosenman Innovator cohort. Criteria include technology, market potential, and how much a startup would benefit from a particular service.
Alloy Product Development
Cloud infrastructure and services
Regulatory, quality, and due diligence research
IP strategy legal session
Cannon Quality Group
Lab bench space, environmental room, quality management services
Cloud data storage, visualization, & analysis
iO life science
Design & engineering consultation, prototyping
IP strategy & counsel
LOK North America
Canadian regulatory & QMS
IP strategy and consultation corporate advisory services
Support with regulatory affairs
IP strategy session
Platform to exchange EHR data
San Francisco VA Health Care System
Strategic clinical consultation
Strategic Marketing Innovations
Strategy for securing federal funding
UCSF Clinical Innovation Center
Consultation on startup strategy and UCSF partnership
IP and startup legal support
Frequently Asked Questions
If you can’t find your answers, please contact us here.
Our company is not based in California or the United States. Are we eligible?
We are not affiliated with a university. Does that affect our application in any way?
Our company is developing a digital technology. Do you only take medical devices?
Companies are eligible if they are in the health technology space, which includes digital health and data solutions.
We are not incorporated yet. Should we apply?
We prefer to select companies that are further along toward commercialization, and incorporation is the first step, so we would not recommend applying. But please consider the program next year.
We do not yet have any funding. Are we eligible?
We are looking for high-growth potential companies that have made some progress, which can include proof-of-concept results or some industry interest. In the past we have selected companies seeking seed-stage through Series A and sometimes Series B.
Are there any specific requirements re: disease or condition that our technology targets?
No, although this year we do offer clinical trial facilitation for selected companies in the TB diagnostics space.